Long-term debt · 2015–2025
AstraZeneca long-term debt
$24.7B−6.8% · FY2025
AstraZeneca (AZN) reported $24.7B in long-term debt for fiscal 2025, −6.8% year on year.
| Fiscal year | Long-term debt | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $24.7B | −6.8% | Open → |
| FY20242024-12-31 | $26.5B | +18.5% | Open → |
| FY20232023-12-31 | $22.4B | −2.6% | Open → |
| FY20222022-12-31 | $23.0B | −18.4% | Open → |
| FY20212021-12-31 | $28.1B | +60.7% | Open → |
| FY20202020-12-31 | $17.5B | +11.3% | Open → |
| FY20192019-12-31 | $15.7B | −9.4% | Open → |
| FY20182018-12-31 | $17.4B | +11.6% | Open → |
| FY20172017-12-31 | $15.6B | +7.3% | Open → |
| FY20162016-12-31 | $14.5B | +2.6% | Open → |
| FY20152015-12-31 | $14.1B | — | Open → |
Long-term debt — Long-term debt is borrowing due more than a year out. A large figure is normal for capital-intensive businesses and says nothing on its own about financial health.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2015–2025 compound annual growth +5.7%
Figures are reported under IFRS, in US dollars.
Long-term debt at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=AstraZeneca long-term debt |url=https://companiesranked.com/en/company/astrazeneca/long-term-debt |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). AstraZeneca long-term debt. CompaniesRanked. https://companiesranked.com/en/company/astrazeneca/long-term-debtBibTeX
@misc{companiesranked-en-company-astrazeneca-long-term-debt-2026,
author = {{CompaniesRanked}},
title = {{AstraZeneca long-term debt}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/astrazeneca/long-term-debt}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 20-F · 0001104659-26-019130 · February 24, 2026
{{cite web |title=AstraZeneca long-term debt — 20-F (0001104659-26-019130) |url=https://www.sec.gov/Archives/edgar/data/901832/000110465926019130/azn-20251231x20f.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-24}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.